J7302 HCPCS code: Levonorgestrel-releasing intrauterine contraceptive system, 52 mg
J7302 is the HCPCS Level II code for levonorgestrel-releasing intrauterine contraceptive system, 52 mg. CMS terminated J7302 on 2015-12-31; do not bill it for later dates of service. Its Medicare coverage code is S (Non-covered by Medicare statute): Medicare is barred by law from covering it.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | S — Non-covered by Medicare statute |
| Pricing indicator | 00 — Not separately priced by Medicare |
| BETOS category | P6C |
| Added | 2002-01-01 |
| Last action effective | 2016-01-01 |
| Terminated | 2015-12-31 |
What changed for J7302
- 2002-01-01: J7302 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7302?
J7302 is the HCPCS Level II code for levonorgestrel-releasing intrauterine contraceptive system, 52 mg. Short descriptor: "Levonorgestrel iu 52 mg".
Does Medicare cover J7302?
Coverage code S — Non-covered by Medicare statute. Medicare is barred by law from covering it.
Related J73 codes
- J7300 — Intrauterine copper contraceptive (paragard)
- J7301 — Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7303 — Contraceptive supply, hormone containing vaginal ring, each
- J7304 — Contraceptive supply, hormone containing patch, each
- J7306 — Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307 — Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308 — Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7309 — Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram
- J7310 — Ganciclovir, 4.5 mg, long-acting implant
- J7311 — Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
- J7312 — Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313 — Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7302
- Watch J7302 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7302
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.